MA29033B1 - Composes organiques - Google Patents

Composes organiques

Info

Publication number
MA29033B1
MA29033B1 MA29924A MA29924A MA29033B1 MA 29033 B1 MA29033 B1 MA 29033B1 MA 29924 A MA29924 A MA 29924A MA 29924 A MA29924 A MA 29924A MA 29033 B1 MA29033 B1 MA 29033B1
Authority
MA
Morocco
Prior art keywords
organic compounds
compounds
organic
Prior art date
Application number
MA29924A
Other languages
English (en)
Inventor
Pascale Hoehn
Bernd Koch
Michael Mutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35501294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29033(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29033B1 publication Critical patent/MA29033B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MA29924A 2004-11-05 2007-05-22 Composes organiques MA29033B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62534304P 2004-11-05 2004-11-05
US64213105P 2005-01-07 2005-01-07

Publications (1)

Publication Number Publication Date
MA29033B1 true MA29033B1 (fr) 2007-11-01

Family

ID=35501294

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29924A MA29033B1 (fr) 2004-11-05 2007-05-22 Composes organiques

Country Status (31)

Country Link
US (2) US8198435B2 (fr)
EP (3) EP2955186A1 (fr)
JP (4) JP5057986B2 (fr)
KR (3) KR101333851B1 (fr)
CN (2) CN102993213A (fr)
AR (1) AR052322A1 (fr)
AU (2) AU2005300693B2 (fr)
BR (1) BRPI0517689A (fr)
CA (1) CA2584911C (fr)
CY (1) CY1113059T1 (fr)
DK (1) DK1812448T3 (fr)
EC (1) ECSP12007431A (fr)
ES (1) ES2388142T3 (fr)
GT (1) GT200500311A (fr)
HK (2) HK1211587A1 (fr)
HR (1) HRP20120652T1 (fr)
IL (3) IL182691A (fr)
JO (1) JO2897B1 (fr)
MA (1) MA29033B1 (fr)
MX (2) MX346525B (fr)
MY (2) MY154878A (fr)
NO (2) NO338960B1 (fr)
NZ (3) NZ599033A (fr)
PE (3) PE20090433A1 (fr)
PL (1) PL1812448T3 (fr)
PT (1) PT1812448E (fr)
RU (2) RU2394038C2 (fr)
SI (1) SI1812448T1 (fr)
TN (1) TNSN07165A1 (fr)
TW (4) TWI433852B (fr)
WO (1) WO2006048296A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101462693B1 (ko) * 2006-08-16 2014-11-17 노파르티스 아게 고도 결정질 치료용 화합물의 고체 분산체 제조 방법
EP2327706A1 (fr) * 2009-11-30 2011-06-01 Novartis AG Formes polymorphiques III et IV de la N-benzoyl-staurosporine
KR20160008267A (ko) 2014-07-14 2016-01-22 주식회사 윈스 네트워크 기반 영상감시체계에서의 사용자 행위 분석 시스템
EP3592749A1 (fr) * 2017-03-06 2020-01-15 Teva Pharmaceutical Works Ltd. Formes à l'état solide de midostaurine
WO2019215759A1 (fr) * 2018-05-09 2019-11-14 Alaparthi Lakshmi Prasad Procédé amélioré de préparation de midostaurine
IT201900004729A1 (it) 2019-03-29 2020-09-29 Procos Spa Processo per la preparazione di midostaurina ad elevato grado di purezza
US20220242880A1 (en) * 2019-06-24 2022-08-04 Dr. Reddy?s Laboratories Limited Process for preparation of midostaurin
IT201900014346A1 (it) 2019-08-08 2021-02-08 Procos Spa Processo per la preparazione di midostaurina amorfa con un basso contenuto di solvente organico residuo
IT202000004291A1 (it) 2020-03-02 2021-09-02 Indena Spa Processo per la purificazione di alcaloidi indolo carbazolici
CN111393454A (zh) * 2020-05-07 2020-07-10 奥锐特药业(天津)有限公司 米哚妥林的新晶型及其制备方法
CN115124551B (zh) * 2021-03-24 2024-04-30 奥锐特药业(天津)有限公司 一种高纯度米哚妥林的制备方法
WO2023205504A1 (fr) * 2022-04-22 2023-10-26 Rutgers, The State University Of New Jersey Formulations et méthodes de traitement de l'épidermolyse bulleuse simple et d'affections associées

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373501A (en) * 1976-12-11 1978-06-30 Kitasato Inst Novel antibiotics amm2282 and process for preparing same
JPS60185719A (ja) 1984-03-06 1985-09-21 Ajinomoto Co Inc 抗腫瘍剤
US5093330A (en) 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
US5073633A (en) * 1989-03-23 1991-12-17 Bristol-Myers Company BMY-41950 antitumor antibiotic
US5096330A (en) * 1990-06-21 1992-03-17 M-B-W Inc. Pitch control mechanism for a surface finishing machine
JPH05247055A (ja) * 1992-03-03 1993-09-24 Meiji Seika Kaisha Ltd スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
JPH05247955A (ja) 1992-03-06 1993-09-24 Taisei Corp 擁壁の施工方法
ES2136103T3 (es) 1992-06-22 1999-11-16 Kyowa Hakko Kogyo Kk Procedimiento para la preparacion de derivados de estaurosporina.
WO1995032975A1 (fr) * 1994-06-01 1995-12-07 Ciba-Geigy Ag Derives d'indolocarbazole destines a sensibiliser a des agents antitumoraux des cellules a resistance multiple aux antitumoraux
RU2191175C2 (ru) 1995-12-11 2002-10-20 Сефалон, Инкорпорейтед Конденсированные изоиндолоны в качестве ингибиторов протеинкиназы с
US6878804B1 (en) 1999-08-30 2005-04-12 University Of Zurich Synthesis of template-fixed β-hairpin loop mimetics
PT1372611E (pt) 2001-03-26 2006-08-31 Novartis Ag Composicao farmaceutica compreendendo uma estaurosporina francamente soluvel em agua, um tensioactivo et um polimero soluvel em agua
KR100407758B1 (ko) 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
US7608420B2 (en) * 2003-04-22 2009-10-27 Lonza Ag Process for the recovery of staurosporine from a fermentation broth

Also Published As

Publication number Publication date
MX2007005429A (es) 2007-05-18
JO2897B1 (en) 2015-09-15
JP2012149099A (ja) 2012-08-09
EP2272850A3 (fr) 2011-09-21
TW200628474A (en) 2006-08-16
CA2584911C (fr) 2017-10-24
PE20060947A1 (es) 2006-10-30
TNSN07165A1 (en) 2008-11-21
CY1113059T1 (el) 2016-04-13
TW201247680A (en) 2012-12-01
EP2272850B1 (fr) 2017-05-10
KR101289998B1 (ko) 2013-07-30
PE20130377A1 (es) 2013-04-03
RU2394038C2 (ru) 2010-07-10
JP5701246B2 (ja) 2015-04-15
KR20070083979A (ko) 2007-08-24
NO338960B1 (no) 2016-11-07
EP1812448B1 (fr) 2012-05-23
KR101265850B1 (ko) 2013-05-20
US8198435B2 (en) 2012-06-12
JP2015063569A (ja) 2015-04-09
IL182691A0 (en) 2007-09-20
PE20090433A1 (es) 2009-05-05
TWI530500B (zh) 2016-04-21
TW201247681A (en) 2012-12-01
WO2006048296A1 (fr) 2006-05-11
NZ554653A (en) 2010-10-29
NZ588025A (en) 2012-04-27
TWI433852B (zh) 2014-04-11
HK1211587A1 (en) 2016-05-27
JP2008518995A (ja) 2008-06-05
HK1108881A1 (en) 2008-05-23
TW201446773A (zh) 2014-12-16
IL182691A (en) 2013-02-28
RU2009137788A (ru) 2011-04-20
ECSP12007431A (es) 2012-06-29
DK1812448T3 (da) 2012-08-27
JP5057986B2 (ja) 2012-10-24
AR052322A1 (es) 2007-03-14
NO20161152A1 (no) 2007-05-30
AU2005300693B2 (en) 2010-08-19
TWI455941B (zh) 2014-10-11
PL1812448T3 (pl) 2012-10-31
MX346525B (es) 2017-03-23
CN102627658A (zh) 2012-08-08
NO20072290L (no) 2007-05-30
MY154878A (en) 2015-08-14
NO340404B1 (no) 2017-04-18
AU2009245817A1 (en) 2009-12-24
EP2955186A1 (fr) 2015-12-16
US8710216B2 (en) 2014-04-29
MY147404A (en) 2012-11-30
AU2005300693A1 (en) 2006-05-11
NZ599033A (en) 2012-09-28
RU2007120695A (ru) 2008-12-10
CA2584911A1 (fr) 2006-05-11
PT1812448E (pt) 2012-08-24
TWI530501B (zh) 2016-04-21
IL217571A (en) 2017-07-31
BRPI0517689A (pt) 2008-10-14
IL207702A0 (en) 2010-12-30
US20090137552A1 (en) 2009-05-28
EP2272850A2 (fr) 2011-01-12
CN102993213A (zh) 2013-03-27
RU2467012C2 (ru) 2012-11-20
KR20120101600A (ko) 2012-09-13
KR101333851B1 (ko) 2013-11-27
IL207702A (en) 2016-09-29
EP1812448A1 (fr) 2007-08-01
SI1812448T1 (sl) 2012-09-28
AU2009245817B2 (en) 2013-02-21
JP2017061578A (ja) 2017-03-30
US20120322789A1 (en) 2012-12-20
ES2388142T3 (es) 2012-10-09
GT200500311A (es) 2006-05-22
KR20120101601A (ko) 2012-09-13
HRP20120652T1 (hr) 2012-09-30

Similar Documents

Publication Publication Date Title
MA29033B1 (fr) Composes organiques
MA28535B1 (fr) Utilisation de composes organiques
MA28357A1 (fr) Composes
NO20084803L (no) organiske forbindelser
IS8513A (is) Lífræn efnasambönd
BRPI0718478A2 (pt) Compostos orgânicos
BRPI0718874A2 (pt) Compostos orgânicos
NO20055688D0 (no) Organiske forbindelser
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
DE602004026114D1 (de) Verweilnadel
DE502005004675D1 (de) Organisches Bauelement
BRPI0712902A2 (pt) compostos orgânicos
MA28933B1 (fr) Nouveaux composes
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
GB2434033B (en) Organic transistor
DE602004026937D1 (de) Bodenstruktur
DK1651034T4 (da) Organiske forbindelser
BRPI0812460A2 (pt) " compostos orgânicos ".
ATA2632004A (de) Ballenauflöser
DE502004003756D1 (de) Bohrspitze
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
NO20055170D0 (no) Organiske forbindelser
AT500473B8 (de) Inkubator
FI20040441A0 (fi) Kylvökone
SE0402103D0 (sv) Novel compounds